Holen Sie sich die Stockscreener-App
92.61
0.47%
-0.44
Schlusskurs vom Vortag:
$93.05
Offen:
$92.98
24-Stunden-Volumen:
555.90K
Relative Volume:
0.62
Marktkapitalisierung:
$7.66B
Einnahmen:
$1.34B
Nettoeinkommen (Verlust:
$230.70M
KGV:
34.69
EPS:
2.6695
Netto-Cashflow:
$440.96M
1W Leistung:
+2.85%
1M Leistung:
-0.05%
6M Leistung:
+9.99%
1J Leistung:
-0.18%
1-Tages-Spanne:
$92.02
$93.96
1-Wochen-Bereich:
$89.67
$93.96
52-Wochen-Spanne:
$72.76
$107.62
Healthequity Inc Stock (HQY) Company Profile
Firmenname
Healthequity Inc
Sektor
Branche
Telefon
801-727-1000
Adresse
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, TEM, BTSG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
92.61 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
VEEV
Veeva Systems Inc
|
296.13 | 47.95B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
70.93 | 12.88B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
63.74 | 12.61B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
102.90 | 8.30B | 646.34M | -512.40M | 202.76M | -6.6871 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-05-22 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-03-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-04-02 | Bestätigt | JP Morgan | Overweight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-21 | Hochstufung | Goldman | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-12 | Eingeleitet | Goldman | Sell |
| 2022-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-03-30 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-12-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-07-02 | Eingeleitet | Stephens | Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-01-07 | Eingeleitet | BTIG Research | Neutral |
| 2020-12-08 | Bestätigt | Barrington Research | Outperform |
| 2020-12-02 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-14 | Eingeleitet | Guggenheim | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-03-17 | Bestätigt | Barrington Research | Outperform |
| 2019-10-07 | Eingeleitet | Goldman | Neutral |
| 2019-09-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-07-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-06-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-03-01 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-12-06 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-05-23 | Eingeleitet | BofA/Merrill | Buy |
| 2018-04-24 | Fortgesetzt | JP Morgan | Overweight |
| 2018-03-20 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-06 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Healthequity Inc Aktie (HQY) Neueste Nachrichten
HealthEquity (MIL:1HQY) Other Long Term Assets : €67.83 Mil (As of Jul. 2026) - GuruFocus
HealthEquity (NASDAQ:HQY) Share Price Breaks Below 50-Day Moving AverageWhat's Next? - MarketBeat
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Healthequity Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
HealthEquity (MIL:1HQY) Cyclically Adjusted Price-to-FCF : (As of Oct. 05, 2026) - GuruFocus
HealthEquity (MIL:1HQY) 10-Year ROIIC % : 8.03% (As of Jan. 2026) - GuruFocus
HealthEquity (MIL:1HQY) Other Gross PPE : €42.13 Mil (As of Jul. 2026) - GuruFocus
HealthEquity (MIL:1HQY) EBIT per Share : €3.60 (TTM As of Jul. 2026) - GuruFocus
MIL:1HQY Dividend: Does HealthEquity Inc Pay a Dividend? - GuruFocus
Who's Buying or Selling HealthEquity Inc (MIL:1HQY) Stock Today? - GuruFocus
MIL:1HQY 3-Year EBITDA Growth Rate: 40.20% — 10% Above Med - GuruFocus
HealthEquity Inc Stock Warning Signs | MIL:1HQY - GuruFocus
HealthEquity Inc (MIL:1HQY) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
HealthEquity: AI Cash Fears Create A 'Buy' Opportunity (NASDAQ:HQY) - Seeking Alpha
(HQY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
A director reports 2,033 shares at HealthEquity (HQY), with delivery upon June 2027 vesting. - Stock Titan
HealthEquity adds Moody’s CFO to board of directors - Investing.com
HealthEquity adds Moody’s CFO to board of directors By Investing.com - Investing.com Nigeria
Noémie Heuland joins HealthEquity board as CFO of Moody’s, to serve on Audit & Cybersecurity committees - TradingView
HealthEquity Appoints Moody’s CFO Noémie Heul - moomoo.com
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors - Yahoo Finance
HealthEquity’s board now has 11 directors, nine independent, after Moody’s finance chief joined. - Stock Titan
HQY5271388 Bond Profile: Coupon and Redemption - TradingView
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo Finance
S&P Global upgrades HealthEquity rating on strong performance - Investing.com
HealthEquity, Inc. (HQY) Stock Forecasts - Yahoo! Finance Canada
BDHEA Releases New Health Equity Playbook to Help Safety-Net Institutions Turn Community Needs into Actionable Solutions - Yahoo Finance
HealthEquity stock holds near USD 94.52 as earnings beat estimates - AD HOC NEWS
HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Liquidity Mapping Around (HQY) Price Events - Stock Traders Daily
HealthEquity, Inc. (HQY) Stock Analysis: Unpacking a 25% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
HealthEquity stock holds near 52-week high after strong first-quarter results - AD HOC NEWS
Healthequity Inc (HQY) Stock News Today - TradingKey
Bank of America Corp DE Invests $103.57 Million in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity Founder Stephen Neeleman Reports Gift of 1,500 Shares in Form 4 Filing - Kalkine Media
After gifting 1,500 shares, HealthEquity (HQY) founder still holds 137,565 - Stock Titan
Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $115 - Moomoo
HealthEquity, Inc. (HQY) Stock Analysis: A Compelling 23.62% Upside Potential - DirectorsTalk Interviews
Amundi Increases Stake in HealthEquity, Inc. $HQY - MarketBeat
Understanding Momentum Shifts in (HQY) - Stock Traders Daily
WINTON GROUP Ltd Invests $4.64 Million in HealthEquity, Inc. $HQY - MarketBeat
29,000 Shares in HealthEquity, Inc. $HQY Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
HealthEquity, Inc. $HQY Shares Bought by Waverly Advisors LLC - MarketBeat
HealthEquity, Inc. $HQY Shares Acquired by Hsbc Holdings PLC - MarketBeat
HealthEquity (HQY) Stock Price, News & Analysis $HQY - MarketBeat
HealthEquity Q2 Results: Earnings release set for August 27 - scanx.trade
Finanzdaten der Healthequity Inc-Aktie (HQY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Healthequity Inc-Aktie (HQY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| James M. Lucania | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
2,822 |
257,240 |
0 |
| Michael Gathright | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
662 |
60,345 |
0 |
| Stephen Neeleman | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
1,095 |
99,815 |
0 |
| Michael Henry Fiore | Former EVP, CCO |
Oct 06 '26 |
Proposed Sale |
91.16 |
2,032 |
185,228 |
0 |
| Scott Cutler | Officer |
Oct 06 '26 |
Proposed Sale |
91.16 |
1,230 |
112,121 |
0 |
| ADRIAN DILLON | Director |
Aug 25 '26 |
Proposed Sale |
105.40 |
7,632 |
804,413 |
0 |
| DILLON ADRIAN T | Director |
Aug 25 '26 |
Sale |
104.61 |
7,632 |
798,373 |
62,395 |
| DILLON ADRIAN T | Director |
Aug 25 '26 |
Option Exercise |
32.50 |
7,632 |
248,040 |
70,027 |
| Fiore Michael Henry | EVP, CHIEF COMMERCIAL OFFICER |
Jul 10 '26 |
Sale |
95.00 |
2,354 |
223,630 |
52,244 |
| MICHAEL FIORE | Officer |
Jul 10 '26 |
Proposed Sale |
94.81 |
2,354 |
223,183 |
0 |
5.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):